Catherine M. Burzik - Oct 15, 2023 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Role
Interim CEO, Director
Signature
/s/ Geoffrey Gillespie, attorney-in-fact
Stock symbol
OFIX
Transactions as of
Oct 15, 2023
Transactions value $
$0
Form type
4
Date filed
10/17/2023, 05:14 PM
Previous filing
Jun 21, 2023
Next filing
Jan 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OFIX Common Stock Award $0 +121K +318% $0.00 159K Oct 15, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in full ninety (90) calendar days following the date that a successor Chief Executive Officer of Issuer assumes office following the Reporting Person's discontinuation of service as Interim Chief Executive Officer of Issuer.
F2 Includes 32,763 previously reported deferred stock units.